Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003654873 | SCV004551550 | likely benign | RASopathy | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004614517 | SCV005098194 | uncertain significance | Cardiovascular phenotype | 2024-03-19 | criteria provided, single submitter | clinical testing | The c.1872G>T (p.L624F) alteration is located in exon 11 (coding exon 11) of the CBL gene. This alteration results from a G to T substitution at nucleotide position 1872, causing the leucine (L) at amino acid position 624 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |